BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
Rhea-AI Summary
BioHarvest Sciences (NASDAQ: BHST) on December 3, 2025 launched VINIA Blood Flow Hydration, a hydration stick-pack powered by VINIA's Piceid resveratrol and red-grape polyphenols entering the $13 billion U.S. electrolyte drink market. The formula delivers 23 mg red-grape polyphenols including 6 mg rapid-absorption Piceid resveratrol, plus naturally sourced electrolytes: 470 mg sodium, 190 mg potassium, and 80 mg magnesium per serving. The product is shipping nationwide via VINIA.com with free North America delivery, will appear on Amazon by end of December 2025, is Informed Sport tested, and is backed by a 90-day “Feel It or It’s Free” guarantee. Clinical support is cited from Vaisman et al., 2015.
Positive
- Product launch targets a $13B U.S. electrolyte market
- Contains 6 mg rapid-absorption Piceid resveratrol per serving
- Per-stick electrolytes: 470 mg Na, 190 mg K, 80 mg Mg
- Available nationwide DTC with Amazon roll-out by end-December 2025
Negative
- Not evaluated by FDA for diagnosis, treatment, cure, or prevention
- Wider retail distribution limited to select outlets; primary channel is DTC
News Market Reaction
On the day this news was published, BHST gained 3.00%, reflecting a moderate positive market reaction. This price movement added approximately $5M to the company's valuation, bringing the market cap to $156M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BHST was down 5.12% while peers showed mixed moves: LFVN down 1.81%, but ABVE, FTLF, DDC, and HAIN were up between 2.75% and 5.82%, suggesting BHST’s weakness was more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Product launch | Positive | +3.0% | Launch of VINIA Blood Flow Hydration into U.S. electrolyte drink market. |
| Nov 13 | Earnings update | Positive | -7.6% | Q3 2025 results with strong revenue growth and guidance toward EBITDA breakeven. |
| Nov 12 | Conference participation | Positive | +14.8% | Announcement of attendance at Craig-Hallum Alpha Select investor conference. |
| Nov 10 | Equity offering close | Neutral | +2.5% | Closing of upsized $19.9M public offering of common stock at $7.00. |
| Nov 07 | Equity offering pricing | Neutral | -8.9% | Pricing of $17.4M underwritten public offering of common shares. |
Recent BHST news often saw strong reactions, with positive strategic or financing updates sometimes met by share price declines, indicating occasional divergence between fundamentals and short-term trading.
Over the last month, BHST combined capital raising with product and commercial milestones. Two November offerings at $7.00 per share raised about $17.4M–$19.9M for manufacturing, R&D, marketing, CDMO expansion, and debt actions. Management then highlighted growth, guidance, and VINIA pipeline at an investor conference on November 18, 2025. Q3 2025 results showed revenue of $9.1M with continued losses but guidance toward adjusted EBITDA breakeven. Today’s VINIA Blood Flow Hydration launch into the $13B U.S. electrolyte market builds directly on that product roadmap and earlier VIP launch commentary.
Market Pulse Summary
This announcement details the U.S. launch of VINIA Blood Flow Hydration, a stick‑pack hydration product combining electrolytes with 23 mg red‑grape polyphenols and 6 mg Piceid resveratrol per serving. It targets the $13B U.S. electrolyte drink market, offers six flavors, and carries a 90‑day money‑back guarantee. Recent history shows BHST pairing product innovation with capital raises and CDMO progress. Investors may watch how online channels, Amazon rollout, and “point‑of‑sweat” distribution convert into revenue, alongside future updates on profitability and cash usage.
Key Terms
electrolytes medical
piceid resveratrol medical
polyphenol medical
informed sport regulatory
iso 17025 technical
AI-generated analysis. Not financial advice.
First Hydration Formula Powered by VINIA's Blood Flow Technology Enters the
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 3, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology platform, announces the U.S. launch of VINIA Blood Flow Hydration™, the first hydration solution powered by the blood flow benefits of VINIA's Piceid resveratrol to enter the
Better Hydration Starts with Better Blood Flow
Following overwhelmingly positive early-adopter interest, VINIA Blood Flow Hydration™ is now shipping nationwide and is available exclusively at Vinia.com, with free delivery across North America. This product introduces a breakthrough concept to the rapidly growing hydration market: Hydration Powered by the Blood Flow benefits of VINIA's Piceid Resveratrol, marking VINIA Blood Flow Hydration™ as the world's first hydration formula with the power of VINIA's rapid absorption Piceid Resveratrol - designed to work synergistically to improve the body's circulation system and more efficiently deliver fluids and electrolytes where the body needs it most.
Example of VINIA Blood Flow Hydration™ packaging, as featured on www.vinia.com
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6168/276772_e695b39234787a4c_001full.jpg
Many hydration drinks focus on WHAT goes in. VINIA Blood Flow Hydration™ goes one step further and improves HOW electrolytes and nutrients get delivered. Containing the finest sources of natural electrolytes, the solution is formulated with premium sodium from sea salt, potassium from coconut water, and magnesium from marine ocean beds. This electrolyte solution is powered by VINIA's unique red grape polyphenol complex (23mg), including rapid absorption Piceid Resveratrol (6mg), which has been clinically shown to significantly increase arterial dilation, improving blood flow**. Better blood flow ensures more efficient transportation of electrolytes and fluids to our body's organs, muscles, and cells, right where they're needed most.
A New Era in Blood Flow-Driven Hydration Science
Dr Suzanne Steinbaum MD, Preventive Cardiologist and Best Selling Author of the "The Heart Health Book: Every Women's Guide to a Heart-Healthy Life", commented "VINIA's Blood Flow Hydration is well named. It is a true 2-in-1 solution because it addresses the problems that are common issues for many people. First, VINIA Blood Flow Hydration increases the dilation of arteries, which improves circulation, and better blood flow is essential to oxygen and nutrient delivery. Second, VINIA Blood Flow Hydration also addresses dehydration, a critical issue for many people, by adding high quality, naturally sourced electrolytes. The combination of water, electrolytes, and VINIA red grape powder's proven ability to improve blood flow with increased dilation enables more efficient delivery of critical fluids and electrolytes to our body's organs, tissues, and cells. That's why I will be recommending VINIA Blood Flow Hydration to my friends and patients."
"My personal experience in leading major brands in the US hydration market while at the Coca-Cola Company have given me the required insights on what is required to drive meaningful differentiation in this multi-billion dollar growing category. I am confident that our strategy of Superior Science, Superior Efficacy and Superior Taste will allow our VINIA Blood Flow Hydration solution to disrupt this market and be a meaningful contributor to driving continued high double-digit revenue growth for the Company," commented Ilan Sobel, CEO of BioHarvest Sciences, adding "No other offering in this rapidly expanding market leverages the power of VINIA's Piceid Resveratrol to address the importance of blood flow in order to drive more effective hydration. Combining the unique, science-based proposition of increased blood flow with a powerful blend of electrolytes derived from nature, we now have 6 great tasting flavors developed by a world class beverage formulator, which gives me the confidence that we can deliver a superior, and Informed Sport Certified, consumer proposition to the market. "
THE FIRST BLOOD-FLOW-HYDRATION SOLUTION DRIVEN BY VINIA'S PICEID RESVERATROL
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6168/276772_e695b39234787a4c_002full.jpg
Six Flavors, Zero Compromise
Developed by a former Coca-Cola flavor formulator, VINIA Blood Flow Hydration™ is available in six light, refreshing flavors: Mixed Berry, Fruit Punch, Watermelon, Summer Orange, Lemonade, and Lemon Lime.
Formulation Highlights
Each stick pack delivers a full daily serving of VINIA®, featuring clinically studied rapid absorption Piceid Resveratrol and naturally sourced electrolytes (470 mg Sodium, 190 mg Potassium, 80 mg Magnesium). The result is a two-in-one formula that hydrates while delivering a steady supply of bioavailable, blood-boosting red-grape polyphenols, representing a major advancement in blood flow driven-hydration science.
Third Party Tested & Trusted
Every batch of VINIA Blood Flow Hydration™ is tested for banned substances under the Informed Sport programme. Products undergo rigorous testing using ISO 17025 accredited methods to provide the highest level of assurance for athletes. For further information about the testing process, please visit informedsport.com.
90-Day "Feel It or It's Free" Guarantee
Every order is backed by BioHarvest's 90-Day "Feel It or It's Free" Guarantee, the industry's strongest consumer promise. Customers can use every stick for 90 days. If they do not love the taste or feel the VINIA® difference, VINIA® will refund the full purchase price and cover return shipping. No questions asked.
The company has announced that VINIA Blood Flow Hydration™ is now available to all online consumers for purchase on VINIA.com and will be available on Amazon.com by the end of December. In addition to being available direct-to-consumer via the company's established e-commerce channels, VINIA Blood Flow Hydration™ will also be distributed via select "point-of-sweat" outlets, to service active consumers looking for premium health solutions.
*Source: https://www.precedenceresearch.com/electrolyte-drinks-market
**Based on BioHarvest sciences clinical trial published in Vaisman et al, 2015, International Journal of Food Sciences and Nutrition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
About BioHarvest
BioHarvest (NASDAQ: BHST) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Launching new products is subject to risks and uncertainties including the risk that the market will not accept the product or that government approvals required for sale or import of the products will not be obtained. There is never an assurance that any product set will successfully disrupt established product categories, as this depends on factors that may be beyond company control such as consumer preferences, competition landscape, acceptance of benefit claims and marketing budgets of the company and its competitors. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
Contacts:
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHST@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276772
FAQ
What did BioHarvest (BHST) announce on December 3, 2025 about VINIA Blood Flow Hydration?
How much Piceid resveratrol and polyphenols are in VINIA Blood Flow Hydration (BHST)?
What are the electrolyte amounts per serving in VINIA Blood Flow Hydration (BHST)?
Where and when can consumers buy VINIA Blood Flow Hydration (BHST)?
Is VINIA Blood Flow Hydration (BHST) tested for athletes and banned substances?
What consumer guarantee does BioHarvest (BHST) offer for VINIA Blood Flow Hydration?
